Tag
29 posts tagged “More strength”.
A neutral, harm-reduction look at ostarine, why it is the mildest of the SARMs, and what to monitor given it still suppresses natural hormones.
A harm-reduction look at ligandrol, why its strength comes with strong hormonal suppression, and the monitoring that actually matters.
A harm-reduction look at RAD-140, its strong anabolic effect, the reported liver-injury signals, and what to monitor closely.
A harm-reduction look at YK-11, a steroidal compound sold as a SARM with myostatin-inhibition claims, and why the human evidence is essentially absent.
A harm-reduction look at methasterone, a potent and markedly hepatotoxic oral steroid, and the monitoring that matters most if someone has already decided to use it.
A harm-reduction look at fluoxymesterone, a strong oral steroid used pre-competition for strength and aggression, with honest framing of its liver and lipid risks.
A harm-reduction look at trestolone, a very potent nandrolone-like injectable that is strongly suppressive and aromatizes to a potent estrogen, and what to monitor.
A harm-reduction look at dihydroboldenone, a non-aromatizing injectable anabolic notorious for post-injection pain, and the monitoring worth doing.
A cautious, harm-reduction look at follistatin and ACE-031, why the human evidence is thin, and what to log if you use them anyway.
A measured, harm-reduction look at testosterone enanthate, what to monitor on TRT or a cycle, and the bloodwork that actually matters.
Cypionate behaves almost identically to enanthate. Here is what to monitor, the bloodwork that matters, and the mistakes to avoid.
Propionate clears fast, which means frequent injections and sharper fluctuations. Here is what that changes about tracking.
A four-ester testosterone blend with a tricky release curve. Why the mixed esters complicate tracking and what to monitor.
A long-ester 19-nortestosterone with a real medical history and serious suppression. What to monitor, including the things people miss.
NPP is nandrolone on a faster ester. Same compound, same risks, more frequent injections. What to track.
A potent 19-nor anabolic with a heavy side-effect load. This is a harm-reduction tracking guide, not an endorsement.
Same potent, high-risk compound as the enanthate version, on a short ester. What the faster clearance changes for tracking.
A long-acting veterinary steroid sometimes used by humans. What it does, the slow timeline, and what to monitor.
A DHT-derived anabolic associated with cutting and "hardening." What that means, what it does not do, and what to monitor.
The longer-acting version of Masteron. Same DHT-derived profile, fewer injections, slower kinetics. What to track.
An oral with a real medical history and a gentle reputation - but real liver, lipid, and suppression concerns. What to monitor.
Fast mass and strength, heavy water retention, and real liver and blood-pressure costs. What to monitor on this classic oral.
A DHT-derived steroid known for a "dry" look - and for hammering cholesterol and joints. What to monitor closely.
Big, fast mass and red-cell effects with heavy liver, blood-pressure, and side-effect load. What to monitor carefully.
A non-aromatising oral known for steady lean gains and a long detection window. What to track and the liver and lipid costs.
A pragmatic tracking guide for MGF, the muscle-damage-responsive splice variant of IGF-1.
What PEG-MGF is, how PEGylation changes the dosing schedule versus regular MGF, and how that changes what you track and when.
A short-acting IGF-1 variant used in research and bodybuilding circles. Here is how to track it honestly.
Long-acting IGF-1 analog with extended half-life. What to measure and what to watch out for.